Follow The Filings

DNA Ginkgo Bioworks Holdings Inc.

Health Care, filed as GINKGO BIOWORKS HOLDINGS INC (CL A NEW), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.1%
  • $35M

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Andreas Halvorsen, Viking Global Investors). Not free-float ownership.

  1. Andreas Halvorsen 0.10%

Who owns DNA

Sorted by value, long equity only, as of 2026 Q2.

History
Andreas Halvorsen, Viking Global Investors 0.10% Hold 3,577,128 $35M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by DNA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All DNA insider trades
  • None no insider bought on the open market
  • $35K sold by 1 insider outside a trading plan
  • $36K sold by 1 insider under 10b5-1 plans
  1. Steven P. Coen See remarks
    Planned sale
    $36K 2,403 shares at $15.00 4.6% of stake
    Traded Oct 5 Filed Oct 7
    ↗
  2. Christian O Henry Director
    Sale
    $35K 5,000 shares at $7.08 21% of stake
    Traded Sep 15 Filed Sep 16
    ↗

Also filed in the last 12 months, not counted as buying or selling: 37 option exercises and 22 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 2.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 2.02 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $251.46M $227.04M $170.16M
Net income -$892.87M -$547.03M -$312.76M
Net margin * -355.1% -240.9% -183.8%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1B $0.603B $0.472B
Total non-current assets * $663.59M $774.7M $647.86M
Total assets $1.67B $1.38B $1.12B
Total current liabilities $163.86M $107.27M $95.97M
Total non-current liabilities * $404.33M $554.12M $515.14M
Total equity — — $508.59M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$295.5M -$319.58M -$171.06M
Cash from investing -$80.69M -$62.24M -$240.29M
Cash from financing -$3.22M -$1.74M $17.78M
Net change in cash -$380M -$383.84M -$393.37M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.